Tuesday, May 23, 2017

Puma Biotechnology Inc. (PBYI) Surged To A 6-Month High

Puma Biotechnology Inc. (PBYI) announced Monday morning that the FDA posted briefing documents on its website ahead of the May 24 Oncologic Drugs Advisory Committee meeting to review breast cancer treatment PB272.

from RTT - Before the Bell http://ift.tt/2qQuppN
via IFTTT

No comments:

Post a Comment